We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Burn Care Market Growth Driven by Biotech Advances

By HospiMedica staff writers
Posted on 10 Dec 2007
A new report projects that the worldwide burn treatment market will experience fluctuating growth due to price constraints, new technologies, and additional market penetration.

A new report by Kalorama Information (New York, NY, USA) has found that conventional, mature products continue to dominate the global burn care market. More...
However, their growth rate is slow and limited by the maturity of the product and the competition. A steady market growth is predicted due to advancements in biotechnology, biomaterials, and an increasing availability of new therapeutic techniques that result in decreasing healing times and subsequent cost savings.

Revolutionary advances using tissue engineering, growth factors, animal-fetal-cell research, stem-cell research, and gene therapy may offer new hope to patients who experience any type of burn, and the numerous products currently in development appear to be the key to successful growth in this market.

"As the wound care markets mature, partnerships are becoming more prevalent as a means of staving off the status quo,” said report author Kalorama analyst Mary Anne Crandall. "Competitors that offer traditional mature products must look for ways to incorporate advanced wound care products for treating burns into their existing products or to improve the existing products significantly to remain competitive with emerging technologies.”

Kalorama Information predicts that the worldwide burn care market will grow from U.S.$1.9 billion in 2006 to $2.5 billion by the year 2011.


Related Links:
Kalorama Information

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.